Advanced search
Publication Cover
Journal of Cosmetic and Laser Therapy Volume 11, 2009 - Issue 3
Submit an article Journal homepage
933
Views
1
CrossRef citations to date
0
Altmetric
LETTER

Differences in botulinum toxins: Time to end the confusion

(Response to Pickett et al. Confusion about diffusion and the art of misinterpreting data when comparing different botulinum toxins in aesthetic applications. J Cosmet Laser Ther. 2008;10:181–3 and Botulinum toxin in aesthetic applications: ‘How often misused words generate misleading thoughts’. J Cosmet Laser Ther. 2009:11:178–9.)

Mitchell F. Brin Senior Vice President Global Development, Chief Scientific Officer, BOTOX, Allergan, Irvine, CA, USA and Professor of Neurology, University of California, Irvine, CA, USACorrespondence[email protected]
,
Kelvin Tan Medical Director, Europe, Allergan, Marlow, UK
&
Conor Gallagher Manager, Medical Affairs, Allergan, Irvine, CA, USA
Pages 180-181 | Received 15 May 2009, Accepted 23 Jun 2009, Published online: 01 Sep 2009

References

  • Pickett A, Dodd S, Rzany B. Confusion about diffusion and the art of misinterpreting data when comparing different botulinum toxins in aesthetic applications. J Cosmet Laser Ther. 2008; 10: 181–3.
  • Pickett A, Rzany B. Botulinum toxin in aesthetic applications: ‘How often misused words generate misleading thoughts’. J Cosmet Laser Ther. 2009; 11: 178–9.
  • De Boulle K. Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids. J Cosmet Laser Ther. 2008; 10: 87–92.
  • Sitte HH. Biologicals and biosimilars. Port J Nephrol Hypert. 2009; 23: 135–9.
  • BOTOX® summary of product characteristics. Marlow, UK: Allergan Ltd; June 2007.
  • Dysport® summary of product characteristics. Slough, UK: Ipsen Ltd; August2007.
  • Nussgens Z, Roggenkamper P. Comparison of two botulinum‐toxin preparations in the treatment of essential blepharospasm. Graefes Arch Clin Exp Ophthalmol. 1997; 935: 197–9.
  • Chapman MA, Barron R, Tanis DC, Gill CE, Charles PD. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia. Clin Ther. 2007; 29: 1325–37.
  • Lowe P, Patnaik R, Lowe N. Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: a double‐blind, randomized study. J Am Acad Dermatol. 2006; 55: 975–80.
  • De Almeida A, Marques E, De Almeida J, Cunha T, Boraso R. Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis. Dermatol Surg. 2007; 33: S37–43.
  • Hexsel D, Dal'Forno T, Hexsel C, Zechmeister Do Prado D, Lima MM. A randomised pilot study comparing the action halos of two commercial preparations of botulinum toxin type A. Dermatol Surg. 2008; 34: 52–9.
  • Rystedt A, Swartling C, Naver H. Anhidrotic effect of intradermal injections of botulinum toxin: a comparison of different products and concentrations. Acta Dermatol Venereol. 2008; 88: 225–33.
  • Kranz G, Haubenberger D, Voller B, Posch M, Schnider P, Auff E, et al. Respective potencies of Botox® and Dysport® in a human skin model: a randomized, double‐blind study. Mov Disord. 2009; 24: 231–6.
  • Wagman J, Bateman JB. Botulinum type A toxin: properties of a toxic dissociation product. Arch Biochem Biophys. 1953; 45: 375–83.
  • Lamanna C, Spero L, Schantz E. Dependence of the time to death on molecular size of botulinum toxin. Infect Immun. 1970; 1: 423–4.
  • Poulain B. How do the botulinum neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action. Botulinum J. 2008; 1: 14–87.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.